We are live on ! Find out more
BIOA

BioAge Labs
BIOA

58 hedge funds and large institutions have $431M invested in BioAge Labs in 2024 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,204.05% more ownership

Funds ownership: 0% → 1,204.05% (+1,204%)

Holders
58
Holders Change
+58
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.1%
New
58
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
AH Capital Management
California
+$60.4M
2
SI
Sofinnova Investments
California
+$46.2M
3
RCM
RA Capital Management
Massachusetts
+$44.3M
4
CAM
Cormorant Asset Management
Massachusetts
+$32.7M
5
SCM
Suvretta Capital Management
New York
+$29.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AH Capital Management
California
$62.7M +$60.4M +3,013,975 New
SI
2
Sofinnova Investments
California
$47.9M +$46.2M +2,304,901 New
RCM
3
RA Capital Management
Massachusetts
$46M +$44.3M +2,210,589 New
CAM
4
Cormorant Asset Management
Massachusetts
$33.9M +$32.7M +1,629,529 New
SCM
5
Suvretta Capital Management
New York
$30.3M +$29.2M +1,455,000 New
O
6
OrbiMed
New York
$29.6M +$28.5M +1,423,470 New
SCV
7
Sands Capital Ventures
Virginia
$22.6M +$21.8M +1,086,353 New
AllianceBernstein
8
AllianceBernstein
Tennessee
$20.7M +$19.9M +994,315 New
RI
9
RTW Investments
New York
$16.4M +$15.8M +786,353 New
PBPIA
10
Pivotal bioVenture Partners Investment Advisor
California
$11M +$10.6M +527,647 New
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$9.36M +$9.01M +449,837 New
RM
12
Redpoint Management
California
$7.97M +$7.68M +383,255 New
Brown Advisory
13
Brown Advisory
Maryland
$6.97M +$6.71M +334,915 New
SL
14
Siren LLC
Connecticut
$6.24M +$6.01M +300,000 New
EA
15
Emerald Advisers
Pennsylvania
$5.85M +$5.64M +281,317 New
CFM
16
Comprehensive Financial Management
California
$5.65M +$5.45M +271,842 New
WA
17
Wasatch Advisors
Utah
$5.3M +$5.11M +254,907 New
EMFAT
18
Emerald Mutual Fund Advisers Trust
Pennsylvania
$4.77M +$4.6M +229,431 New
Citadel Advisors
19
Citadel Advisors
Florida
$4.45M +$4.28M +213,718 New
Fidelity International
20
Fidelity International
Bermuda
$4.16M +$4.01M +200,000 New
JP Morgan Chase
21
JP Morgan Chase
New York
$4.16M +$4.01M +200,000 New
Marshall Wace
22
Marshall Wace
United Kingdom
$4.16M +$4.01M +200,000 New
Millennium Management
23
Millennium Management
New York
$3.45M +$3.33M +166,022 New
Alyeska Investment Group
24
Alyeska Investment Group
Illinois
$3.12M +$3.01M +150,000 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
25
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$3.12M +$3.01M +150,000 New
1
2 3

BIOA Hedge Fund Activity: Q3 2024 in Review

58 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q3 2024, worth a combined $431M.

Buyers outnumbered sellers: 58 funds opened new BIOA positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was AH Capital Management, opening a new position worth an estimated $60.4M.

  • 58 institutional investors held BioAge Labs (BIOA) as of Q3 2024, up from 0 in Q2 2024.
  • Funds reported $431M of BioAge Labs stock for Q3 2024.
  • 58 funds opened new BioAge Labs positions in Q3 2024 and 0 closed out, a net change of +58 holders.
  • The largest BioAge Labs buyer in Q3 2024 was AH Capital Management, an estimated $60.4M added.

Based on aggregated 13F filings for Q3 2024.